ITS Raises Series A

Immune Targeting Systems Ltd., a London-based developer of synthetic vaccines for mutating viruses, has raised Gbp3.5 million in Series A funding. Participants included Novartis Venture Fund, Truffle Capital, HealthCap and the London Technology Fund. ITS also has received a Gbp500,000 research grant from The London Development Agency.